Patents by Inventor Stefan Hannus

Stefan Hannus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alkali metal salt for use in treatment of mite infestation of honey bees
    Patent number: 11723366
    Abstract: The present disclosure relates to the use of alkali metal salts and preferably lithium chloride for treatment of Varroa destructor infestation of honey bees.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: August 15, 2023
    Assignees: Universität Hohenheim, siTools Biotech GmbH
    Inventors: Stefan Hannus, Peter Rosenkranz, Bettina Ziegelmann
  • Alkali metal salt for use in treatment of varroa destructor mite infestation of honey bees
    Patent number: 10980238
    Abstract: The present disclosure relates to the use of alkali metal salts and preferably lithium chloride for treatment of Varroa destructor infestation of honey bees.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: April 20, 2021
    Assignees: Universität Hohenheim, siTools Biotech GmbH
    Inventors: Stefan Hannus, Peter Rosenkranz, Bettina Ziegelmann
  • Alkali metal salt for use in treatment of mite infestation of honey bees
    Patent number: 10375963
    Abstract: The present disclosure relates to the use of alkali metal salts and preferably lithium chloride for treatment of Varroa destructor infestation of honey bees.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: August 13, 2019
    Inventors: Stefan Hannus, Peter Rosenkranz, Bettina Ziegelmann
  • Raf inhibitors
    Patent number: 8232283
    Abstract: The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are inhibitors or kinases such as Raf, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: July 31, 2012
    Assignee: Forma Therapeutics, Inc.
    Inventors: Andreas Schoop, Alexander Backes, Joachim Vogt, Lars Neumann, Jan Eickhoff, Stefan Hannus, Kerrin Hansen, Peter Amon, Igor Ivanov, Matthias Borgmann, Chase Smith, Arthur F. Kluge, Krishan Murthi, Rebecca Casaubon
  • USE OF FCCS FOR THE ANALYSIS OF INTERACTION PARAMETERS IN AN IN VIVO-LIKE ENVIRONMENT
    Publication number: 20120021942
    Abstract: The present invention relates to the determination of interaction parameters of at least two analytes in cellular lysates, wherein at least one competitive agent is optionally further present.
    Type: Application
    Filed: February 1, 2010
    Publication date: January 26, 2012
    Applicant: INTANA BIOSCIENCE GMBH
    Inventors: Kerrin Hansen, Stefan Hannus, Frank Becker